Short‐term prophylaxis in hereditary angioedema due to deficiency of the C1‐inhibitor – a long‐term survey

Hereditary angioedema is a potentially life‐threatening disorder, because edema occurring in the mucosa of the upper airways can lead to suffocation. The management of HAE consists of avoiding the triggering factors, prophylaxis, and the acute treatment of edematous episodes. Medical procedures can also provoke edematous attacks, and therefore, short‐term prophylaxis (STP) is recommended before such interventions. Our aim was to evaluate the efficacy and safety of STP administered before medical procedures.

[1]  Avantika Golas.  Contact activation of blood-plasma coagulation , 2012 .

[2]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[3]  M. Cicardi,et al.  Target levels of functional C1‐inhibitor in hereditary angioedema , 2012, Allergy.

[4]  T. Machnig,et al.  C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study , 2011, Allergy.

[5]  P. Howarth,et al.  New topics in bradykinin research , 2011, Allergy.

[6]  B. Chipps.  Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema , 2011, Pediatrics.

[7]  K. Bork,et al.  Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[8]  W. Lumry,et al.  Pre-procedure Administration of C1 Esterase Inhibitor (Human) (Cinryze™) for the Prevention of Hereditary Angioedema (HAE) Attacks after Medical, Dental, or Surgical Procedures , 2011 .

[9]  J. Bernstein,et al.  Successful C1 inhibitor short-term prophylaxis during redo mitral valve replacement in a patient with hereditary angioedema , 2010, Journal of cardiothoracic surgery.

[10]  A. Kaplan,et al.  The plasma bradykinin-forming pathways and its interrelationships with complement. , 2010, Molecular immunology.

[11]  T. Bowen.  Hereditary Angioedema Consensus 2010 , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[12]  J. V. Van Sickels,et al.  Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[13]  J. Clotet,et al.  Short‐term prophylactic treatment of hereditary angioedema with icatibant , 2010, Allergy.

[14]  J. Bernstein,et al.  Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. , 2009, The Journal of allergy and clinical immunology.

[15]  E. Vogler,et al.  Contact activation of blood-plasma coagulation. , 2009, Biomaterials.

[16]  M. Cicardi,et al.  C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.

[17]  H. Farkas,et al.  Disease expression in women with hereditary angioedema. , 2008, American journal of obstetrics and gynecology.

[18]  G. Kojda,et al.  Nonallergic angioedema: role of bradykinin , 2007, Allergy.

[19]  H. Farkas,et al.  Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. , 2007, Helicobacter.

[20]  M. Gompels,et al.  C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.

[21]  A. Tordai,et al.  Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond , 2004, Journal of Allergy and Clinical Immunology.

[22]  Shinsuke Nomura,et al.  Management of oral surgery in patients with hereditary or acquired angioedemas: review and case report. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[23]  K. Bork,et al.  Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. , 2003, Journal of the American Dental Association.

[24]  H. Farkas,et al.  The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures. , 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[25]  M. Tosi.  Molecular genetics of C1 inhibitor. , 1998, Immunobiology.

[26]  A. Kaplan,et al.  Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  P. Spaeth,et al.  Hereditary angioedema: uncomplicated maxillofacial surgery using short-term C1 inhibitor replacement therapy. , 1993, International archives of allergy and immunology.

[28]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[29]  M. Frank,et al.  Oral manifestations and dental management of patients with hereditary angioedema. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[30]  R. Grisius,et al.  Hereditary angioedema controlled with danazol. Report of a case. , 1979, Oral surgery, oral medicine, and oral pathology.

[31]  J. Atkinson,et al.  Hereditary angioedema: the use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. , 1975, The Journal of allergy and clinical immunology.

[32]  H. Pence,et al.  Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema. , 1974, The Journal of allergy and clinical immunology.

[33]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[34]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.